Rocket Pharmaceuticals, Inc.
RCKT
$3.47
$0.133.89%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 67.52M | 75.11M | 86.50M | 97.15M | 105.91M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 191.88M | 212.64M | 228.52M | 247.18M | 264.18M |
| Operating Income | -191.88M | -212.64M | -228.52M | -247.18M | -264.18M |
| Income Before Tax | -8.63M | -209.38M | -223.12M | -240.91M | -257.30M |
| Income Tax Expenses | 8.62M | -- | -- | -- | -- |
| Earnings from Continuing Operations | -17.25 | -209.38 | -223.12 | -240.91 | -257.30 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.25M | -209.38M | -223.12M | -240.91M | -257.30M |
| EBIT | -191.88M | -212.64M | -228.52M | -247.18M | -264.18M |
| EBITDA | -182.18M | -202.46M | -217.49M | -236.01M | -253.87M |
| EPS Basic | -0.16 | -1.88 | -2.01 | -2.25 | -2.51 |
| Normalized Basic EPS | -1.07 | -1.19 | -1.28 | -1.43 | -1.59 |
| EPS Diluted | -0.18 | -1.88 | -2.01 | -2.25 | -2.51 |
| Normalized Diluted EPS | -1.07 | -1.19 | -1.28 | -1.43 | -1.59 |
| Average Basic Shares Outstanding | 448.34M | 446.51M | 444.47M | 430.21M | 412.80M |
| Average Diluted Shares Outstanding | 450.01M | 446.51M | 444.47M | 430.21M | 412.80M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |